COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,763 Articles (22,502 medRxiv, 8,261 bioRxiv)

Most recent first Previous |  Page 303: Articles 3021-3030  | Next

How will COVID-19 persist in the future? Simulating future dynamics of COVID-19 using an agent-based network model
Roubenoff, E.
10.1101/2023.08.29.23294791 — Posted: 2023-09-01
Can long-term COVID-19 vaccination be improved by serological surveillance?: a modeling study for Mozambique
Liu, C. Y., Shioda, K., Kraay, A., Massora, S., de Jesus, A., Massinga, A., Monjane, C., Omer, S. B., Jenness, S. M., Nelson, K., Flasche, S. Y., Mandomando, I., Lopman, B. A.
10.1101/2023.08.29.23294793 — Posted: 2023-09-01
Symptom experience before vs. after confirmed SARS-CoV-2 infection: a population and case control study using prospectively recorded symptom data.
Sudre, C. H., Antonelli, M., Cheetham, N. J., Molteni, E., Canas, L. S., Bowyer, V., Murray, B., Rjoob, K., Modat, M., Capdevia Pujol, J., Hu, C., Wolf, J., Spector, T. D., Hammers, A., Steves, C. J., Ourselin, S., Duncan, E. L.
10.1101/2023.08.30.23294821 — Posted: 2023-09-01
Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated Beta-2-Adrenergic Receptor Autoantibodies
Stein, E., Heindrich, C., Wittke, K., Kedor, C., Kim, L., Freitag, H., Krueger, A., Toelle, M., Scheibenbogen, C.
10.1101/2023.08.31.23294813 — Posted: 2023-09-01
Effectiveness of ReCOVery APP to improve the quality of life of Long COVID patients: a 6-month follow-up randomized clinical trial.
Samper-Pardo, M., Olivan-Blazquez, B., Leon-Herrera, S., Sanchez Arizcuren, R., Casado-Vicente, V., Sanchez-Recio, R.
10.1101/2023.08.30.23294831 — Posted: 2023-09-01
Changes in child and adolescent mental health across the COVID-19 pandemic (2018-2023): Insights from general population and clinical samples in the Netherlands
van Oers, H. A., Alrouh, H., Tieskens, J. M., Luijten, M. A. J., de Groot, R., Broek, E., van der Doelen, D., Klip, H., de Meyer, R., van der Mheen, M., Ruisch, H., van den Berg, G., Bruining, H., Buitelaar, J., van der Rijken, R., Hoekstra, P. J., Kleinjan, M., Lindauer, R., Oostrom, K. J., Staal, W., Vermeiren, R., Cornet, R., Haverman, L., Popma, A., Bartels, M., Polderman, T. J. C., Zijlmans, J.
10.1101/2023.08.29.23294764 — Posted: 2023-09-01
Effects of Specific Protective Resources on the Burnout Levels of Selected Visayan Medical Students from Online-Based Education during COVID-19 Pandemic: A Cross-Sectional Study
Arpilleda, J. J., Bunal, J. P., Montano, M. T., Torrenueva, L. M., Acebes, M. J., Homecillo, M., Salvador, J. P., Tan, F. G., Villanueva, Z.
10.1101/2023.08.28.23294675 — Posted: 2023-09-01
The COVID-19 pandemic has increased health inequalities by altering patterns of engagement with a mass participation event after resumption post-lockdown
Gilburn, A. S.
10.1101/2023.08.30.23294836 — Posted: 2023-09-01
Sequential early-life viral infections modulate the microbiota and adaptive immune responses to systemic and mucosal vaccination
Li, Y., Molleston, J. M., Kim, A. H., Ingle, H., Aggarwal, S., Nolan, L., Hassan, A., Foster, L., Diamond, M., Baldridge, M. T.
10.1101/2023.08.31.555772 — Posted: 2023-09-01
Characterization of an EG.5.1 clinical isolate in vitro and in vivo
Uraki, R., Kiso, M., Iwatsuki-Horimoto, K., Yamayoshi, S., Ito, M., Chiba, S., Sakai-Tagawa, Y., Imai, M., Kashima, Y., Koga, M., Fuwa, N., Okumura, N., Hojo, M., Iwamoto, N., Kato, H., Nakajima, H., Ohmagari, N., Yotsuyanagi, H., Suzuki, Y., Kawaoka, Y.
10.1101/2023.08.31.555819 — Posted: 2023-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).